Lilly
  • House For Healthcare Providers
Skip to main content
Warning

For healthcare provider information on bamlanivimab and etesevimab together, click here.

Download Dear HCP Letter: Revocation of Bamlanivimab Alone EUA

Healthcare providers should direct questions about the revocation of Emergency Use Authorization (EUA) 90, bamlanivimab alone, to Eli Lilly and Company at 1-855-LillyC19 (1-855-545-5921).

Terms of Use
Privacy Statement
Accessibility Statement
Sitemap

This site is intended for US healthcare providers only.

PP-BM-US-0166 04/2021 ©Lilly USA, LLC 2021. All rights reserved.

All product/company names shown herein are the trademarks of their respective owners.

Terms of Use Privacy Statement Accessibility Statement Sitemap
Lilly